25CN-NBOH

25CN-NBOH
Clinical data
Other names	NBOH-2C-CN
Drug class	Selective serotonin 5-HT2A receptor agonist
Legal status
Legal status	UK: Class A; Illegal in Hungary;
Identifiers
	IUPAC name 4-[2-[(2-hydroxyphenyl)methylamino]ethyl]-2,5-dimethoxybenzonitrile;
CAS Number	1391489-32-9 ;
PubChem CID	90489020;
ChemSpider	58191431;
UNII	32CN2DQE3Q;
CompTox Dashboard (EPA)	DTXSID301017253 ;
Chemical and physical data
Formula	C18H20N2O3
Molar mass	312.369 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc1cc(C#N)c(OC)cc1CCNCc2ccccc2O;
	InChI InChI=1S/C18H20N2O3/c1-22-17-10-15(11-19)18(23-2)9-13(17)7-8-20-12-14-5-3-4-6-16(14)21/h3-6,9-10,20-21H,7-8,12H2,1-2H3; Key:VWEDZTZAXHMZIL-UHFFFAOYSA-N;

25CN-NBOH, also known as NBOH-2C-CN, is a compound indirectly derived from the phenethylamine series of hallucinogens, which was discovered in 2014 at the University of Copenhagen. It is a member of the NBOMe family of psychedelics.

The drug is notable in being one of the most selective agonists of the serotonin 5-HT_2A receptor known.

A tritiated version of 25CN-NBOH has also been accessed and used for more detailed investigations of the binding to serotonin 5-HT₂ receptors and autoradiography.